Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-000433
Filing Date
2024-01-25
Accepted
2024-01-24 21:45:41
Documents
51
Period of Report
2023-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR NOV 2023 cannabis_i10q-113023.htm   iXBRL 10-Q 513661
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL ACCOUNTING OFFICER cannabis_ex3100.htm EX-31 11055
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 USC SECTION 1350 cannabis_ex3200.htm EX-32 3371
  Complete submission text file 0001683168-24-000433.txt   2886431

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cbih-20231130.xsd EX-101.SCH 26148
5 XBRL CALCULATION FILE cbih-20231130_cal.xml EX-101.CAL 38824
6 XBRL DEFINITION FILE cbih-20231130_def.xml EX-101.DEF 71602
7 XBRL LABEL FILE cbih-20231130_lab.xml EX-101.LAB 196615
8 XBRL PRESENTATION FILE cbih-20231130_pre.xml EX-101.PRE 154491
45 EXTRACTED XBRL INSTANCE DOCUMENT cannabis_i10q-113023_htm.xml XML 302541
Mailing Address 6201 BONHOMME ROAD SUITE 466S HOUSTON TX 77036
Business Address 6201 BONHOMME ROAD SUITE 466S HOUSTON TX 77036 214-733-0868
Cannabis Bioscience International Holdings, Inc. (Filer) CIK: 0001411057 (see all company filings)

EIN.: 844901229 | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 333-146758 | Film No.: 24558424
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)